These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 26790718

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
    Lin X, Xu Y, Tang X, Zhang Y, Chen J, Zhang Y, He H, Yang Z.
    Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
    [Abstract] [Full Text] [Related]

  • 4. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y, Yu Y, Tang X.
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [Abstract] [Full Text] [Related]

  • 5. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
    Wang JW, Xu JH, Li J, Zhao MH, Zhang HF, Liu DC, Zhou X, Xu H.
    J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.
    Lin X, Yang S, Gou J, Zhao M, Zhang Y, Qi N, He H, Cai C, Tang X, Guo P.
    J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate.
    Lee ES, Kwon MJ, Lee H, Na K, Kim JJ.
    Eur J Pharm Sci; 2006 Dec; 29(5):435-41. PubMed ID: 16978848
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
    Guo Y, Yang Y, He L, Sun R, Pu C, Xie B, He H, Zhang Y, Yin T, Wang Y, Tang X.
    Pharm Res; 2017 Oct; 34(10):2211-2222. PubMed ID: 28741064
    [Abstract] [Full Text] [Related]

  • 15. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV, Couet W, Olivier JC.
    Int J Pharm; 2011 Jul 29; 414(1-2):112-7. PubMed ID: 21596123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP, Vavia PR.
    Pharm Dev Technol; 2014 Jun 29; 19(4):385-94. PubMed ID: 23590187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.